Evolent Health, Inc. (EVH)
3.53
+0.07
(+2.02%)
USD |
NYSE |
Oct 05, 12:45
Evolent Health Gross Profit Margin (Quarterly) : 9.08% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.08% |
| March 31, 2026 | 12.48% |
| December 31, 2025 | 11.14% |
| September 30, 2025 | 15.82% |
| June 30, 2025 | 17.32% |
| March 31, 2025 | 16.17% |
| December 31, 2024 | 7.18% |
| September 30, 2024 | 8.21% |
| June 30, 2024 | 11.85% |
| March 31, 2024 | 11.66% |
| December 31, 2023 | 12.95% |
| September 30, 2023 | 17.95% |
| June 30, 2023 | 18.05% |
| March 31, 2023 | 20.49% |
| December 31, 2022 | 16.29% |
| September 30, 2022 | 19.42% |
| June 30, 2022 | 17.23% |
| March 31, 2022 | 20.94% |
| December 31, 2021 | 27.70% |
| September 30, 2021 | 20.00% |
| June 30, 2021 | 15.50% |
| March 31, 2021 | 19.55% |
| December 31, 2020 | 23.12% |
| Date | Value |
|---|---|
| September 30, 2020 | 18.06% |
| June 30, 2020 | 16.99% |
| March 31, 2020 | 13.39% |
| December 31, 2019 | 15.89% |
| September 30, 2019 | 17.34% |
| June 30, 2019 | 16.77% |
| March 31, 2019 | 14.31% |
| December 31, 2018 | 33.99% |
| September 30, 2018 | 43.77% |
| June 30, 2018 | 45.23% |
| March 31, 2018 | 41.69% |
| December 31, 2017 | 33.54% |
| September 30, 2017 | 31.24% |
| June 30, 2017 | 30.05% |
| March 31, 2017 | 30.21% |
| December 31, 2016 | 24.58% |
| September 30, 2016 | 37.47% |
| June 30, 2016 | 35.61% |
| March 31, 2016 | 35.33% |
| December 31, 2015 | 39.48% |
| September 30, 2015 | 31.15% |
| June 30, 2015 | 14.82% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| DarioHealth Corp. | 61.66% |
| CompuMed, Inc. | 49.53% |
| Teladoc Health, Inc. | 53.58% |
| Renalytix Plc | -- |
| Lifestance Health Group, Inc. | 31.88% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -86.09% |
| Return on Assets | -23.68% |
| Return on Invested Capital | -31.39% |
| Profit Margin (Quarterly) | -4.35% |
| Operating Margin (Quarterly) | -1.34% |
| Return on Net Operating Assets | -26.32% |